Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 28, 2006; 12(12): 1874-1880
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1874
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1874
Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls
Juris J Meier, Bartholomaeus Kask, Wolfgang E Schmidt, Baptist Gallwitz, Department of Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Germany
Michael A Nauck, Diabeteszentrum Bad Lauterberg, Germany
Jens J Holst, Carolyn F Deacon, Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark
Baptist Gallwitz, Department of Medicine IV, Eberhard-Karls-University, Tübingen, Germany
Supported by the Wilhelm-Sander-Stiftung (No. 2002.025.1 to JJM), Deutsche Forschungsgemeinschaft (grants Me 2096/2-1, Na 203/6-1 and Ga 386/8-1) and the Deutsche Diabetes Gesellschaft (to JJM)
Correspondence to: Dr. Juris J Meier, Department of Medicine I, St. Josef-Hospital, Ruhr-University of Bochum Gudrunstr. 56 44791 Bochum, Germany. juris.meier@rub.de
Telephone: +49-234-509-2712/-1 Fax: +49-234-509-2309
Received: June 9, 2005
Revised: July 2, 2005
Accepted: August 26, 2005
Published online: March 28, 2006
Revised: July 2, 2005
Accepted: August 26, 2005
Published online: March 28, 2006
Core Tip